MYNZ Mainz Biomed B.V.
Healthcare$3.59+0.84%ClosedMarket Cap: $14.7M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
8.56
P/S
145.36
EV/EBITDA
-4.97
DCF Value
$-1.68
FCF Yield
-13.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-2723.5%
Net Margin
-2937.8%
ROE
-244.2%
ROA
-109.1%
ROIC
-165.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $250.4K | 33.7% | $-5.4M | $-7.9M | $— | — |
| FY null | $537.1K | -42.1% | $-13.5M | $-16.2M | $— | — |
| Q2 null | $286.7K | -108.2% | $-8.1M | $-8.3M | $— | — |
| Q4 null | $373.2K | 68.6% | $-8.9M | $-10.6M | $— | — |
| FY null | $894.0K | 64.3% | $-18.7M | $-21.7M | $— | — |
| Q2 null | $520.8K | 61.3% | $-9.8M | $-11.0M | $— | — |
| Q4 null | $214.8K | 18.7% | $-12.2M | $-5.2M | $— | — |
| FY null | $895.5K | 56.9% | $-26.6M | $-26.3M | $— | — |
| Q2 null | $500.2K | 55.6% | $-13.0M | $-13.3M | $— | — |
| Q4 null | $251.4K | 13.3% | $-12.3M | $-12.6M | $— | — |
| FY null | $529.9K | 34.4% | $-26.4M | $-26.5M | $— | — |
| Q2 null | $278.5K | 53.4% | $-13.9M | $-13.9M | $— | — |